JAGX Jaguar Animal Health Forward Price-to-Revenue Multiple

Corporate emblem and logo of Jaguar Health Corp (JAGX)

Jaguar Health, Inc. (JAGX) generates revenue through the patent protection of a unique plant-based gastrointestinal remedy. This chart on GURU.Markets illustrates how the forward P/S multiple reacts to demand, and 0.20 captures a new level. Sales of the drug for oncology provide stability, ignoring macro trends. Business development relies on ESG culture and the recruitment of botanical medicine experts through RSU shares.

Jaguar Health - JAGX Forward P/S Multiple (period 07/04/2022 - 11/17/2026)

Comprehensive metric breakdowns and analytics for Jaguar Health, Inc. (JAGX)

- current price and projected stock value:
Summary company analysis:jaguar.health JAGX
Manufactured products of Jaguar Health Corp

Market expectations for Jaguar Health, Inc. (JAGX) reflect a balance between speculative demand and the commercialization potential of its plant-based gastrointestinal treatments. The projected P/S multiple, calculated as the ratio of market capitalization to forecasted revenue, allows for a valuation of the innovator's future cash flows, separating the fundamental business growth trend from short-term price volatility.